4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000024
Chief Medical Officer sold 416 shares at $31.33 ($13,033)
- Chief Medical Officer acquired 416 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2026-04-17 | Option exercise 10b5-1 | +416 | $15.44 | $6,423 | 70,208 | D |
| Rodman David Malcom Chief Medical Officer | 2026-04-17 | Sale 10b5-1 | −416 | $31.33 | $13,033 | 69,792 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2026-04-17 | Option exercise · Stock Option 10b5-1 | −416 | 4,584 | D | ||
| Open-market sales · 416 sh · avg $31.33 · $13,033 | |||||||
Loading xslF345X06/wk-form4_1776812373.xml…